Diethylamine

Diethylamine

SCHEMBL6655360

C1=Cc2ccccc2SN=C1.CCNCC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL27591126 0.87
SCHEMBL29901519 0.86 TRPA1 (0.31)
SCHEMBL19983 0.86 TRPA1 (0.31)
Ammonia Solution, Strong SCHEMBL27596721 0.84 TRPA1 (0.31)
SCHEMBL433359 0.84 TRPA1 (0.31)
Hydrochloric Acid SCHEMBL7403491 0.84 TRPA1 (0.31)
Hydrogen Sulfide SCHEMBL27732874 0.84 TRPA1 (0.31)
SCHEMBL27543379 0.84 TRPA1 (0.31)
SCHEMBL27611235 0.84 TRPA1 (0.31)
Cycloheptane SCHEMBL27301709 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1639140-A Benzothiazepine * derivatives for the treatment of hyperlipidemia ASTRAZENECA AB (SE) 2005-07-13 CN disclosed
EP-1427713-A1 BENZOTHIAZEPINE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDEMIA Astrazeneca AB (SE) 2004-06-16 EP disclosed
WO-2003022825-A1 BENZOTHIAZEPINE DERIVATIVES FOR THE TREATMENT OF HYPERLIPIDEMIA ASTRAZENECA AB (SE) 2003-03-20 WO disclosed